1. Improvement of Staging by Combining Tumor and Treatment Parameters: The Value for Prognostication in Rectal Cancer 
Marleen J.E.M. Gosens, J. Han J.M. van Krieken, Corrie A.M. Marijnen, Elma Meershoek-Klein Kranenbarg, Hein Putter, Harm J. Rutten, Krzysztof Bujko, Cornelis J.H. van de Velde, Iris D. Nagtegaal 
Clinical Gastroenterology and Hepatology 
Volume 5, Issue 8, Pages (August 2007)
DOI: /j.cgh
Copyright © 2007 AGA Institute Terms and Conditions

2. Figure 1
Kaplan–Meier curves for survival. (A) TNM staging, (B) Jass’ staging, and (C) NCRM staging. NCRM 0 (0 adverse factors: N0CRM−), NCRM 1 (1 adverse factor: N0CRM+ or N1CRM-), NCRM 2 (2 adverse factors: N2CRM− or N1CRM+), NCRM 3 (3 adverse factors: N2CRM+). For each category the percentage of patients is given.
Clinical Gastroenterology and Hepatology 2007 5, DOI: ( /j.cgh )
Copyright © 2007 AGA Institute Terms and Conditions

3. Figure 2
Kaplan–Meier curves for survival in the independent test population. (A) TNM staging and (B) NCRM staging. For each category the percentage of patients is given.
Clinical Gastroenterology and Hepatology 2007 5, DOI: ( /j.cgh )
Copyright © 2007 AGA Institute Terms and Conditions